As of June 16, 2025, Nexus Biopharma Inc (NEXS) reports a Current Ratio of 0.00.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Nexus Biopharma Inc's Current Ratio
Over recent years, Nexus Biopharma Inc's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2017-02-28 | 0.00 |
| 2015-12-31 | - |
| 2014-12-31 | 0.10 |
| 2013-12-31 | - |
| 2012-12-31 | 0.01 |
This slight downward trend highlights how Nexus Biopharma Inc manages its short-term assets and liabilities over time.
Comparing Nexus Biopharma Inc's Current Ratio to Peers
To better understand Nexus Biopharma Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Nexus Biopharma Inc (NEXS) | 0.00 |
| Immage Biotherapeutics Corp (IMMG) | 3.67 |
| Terminus Energy Inc (TMGY) | 1.86 |
| Sustainable Projects Group Inc (SPGX) | 0.86 |
| Gooi Global Inc (GOOI) | 0.62 |
| BlueFire Equipment Corp (BLFR) | 0.49 |
Compared to its competitors, Nexus Biopharma Inc's Current Ratio is about average compared to peers, reflecting balanced short-term asset management.